RaySearch Laboratories AB (publ) (LON: 0GRZ)

Market Cap	577.40M
Revenue (ttm)	86.00M
Net Income (ttm)	12.88M
Shares Out	n/a
EPS (ttm)	0.38
PE Ratio	44.84
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	353
Average Volume	1,086
Open	228.50
Previous Close	228.00
Day's Range	226.50 - 230.00
52-Week Range	6.15 - 15.70
Beta	1.34
RSI	60.59
Earnings Date	Feb 21, 2025

About RaySearch Laboratories AB

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer care in the Americas, Europe, Africa, the Asia-Pacific, and the Middle East. It develops and markets RayStation, a treatment planning system for radiation therapy; RayCare, an oncology information system that manages clinical activities; RayIntelligence, a cloud-based analytics system for monitoring and enhancement of cancer therapy; and RayCommand, a treatment control system that serves as link between the treatment machine and the treatment ...

• Industry: Prepackaged Software
• Founded: 1988
• Employees: 389
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0GRZ

Financial Performance

In 2023, RaySearch Laboratories AB's revenue was 1.02 billion, an increase of 21.16% compared to the previous year's 843.65 million. Earnings were 81.57 million, an increase of 243.06%.

Financial numbers in SEK